We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+5.94%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$830M
AUM Growth
+$70.8M
(+9.3%)
Cap. Flow
+$31.3M
Cap. Flow
% of AUM
3.77%
Top 10 Holdings %
Top 10 Hldgs %
42.39%
Holding
84
New
4
Increased
26
Reduced
27
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$28.2M |
| 2 |
Advanced Micro Devices
AMD
|
+$25.5M |
| 3 |
McKesson
MCK
|
+$21.9M |
| 4 |
Teradyne
TER
|
+$19M |
| 5 |
Intuit
INTU
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$19.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$18.3M |
| 3 |
Micron Technology
MU
|
+$17M |
| 4 |
Broadcom
AVGO
|
+$17M |
| 5 |
Alibaba
BABA
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.99% |
| 2 | Consumer Discretionary | 16.28% |
| 3 | Healthcare | 14.61% |
| 4 | Financials | 12.87% |
| 5 | Communication Services | 8.54% |
Similar funds
ECA
DWML
BOA
PLU
CPW
AWM
CAAM
SCP
De Burlo Group's Q3 2025 Portfolio in Review
As of Q3 2025, De Burlo Group held 84 positions worth $830M, up 9.3% from $759M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
De Burlo Group deployed $31.3M of net new capital in Q3 2025, opening 4 new positions and adding to 26 existing holdings. Its largest new stake was Novo Nordisk: 481,160 shares worth $26.7M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $18.3M trimmed.
- De Burlo Group's largest Q3 2025 buy was Novo Nordisk: 481,160 shares worth $26.7M.
- De Burlo Group added most to Advanced Micro Devices in Q3 2025, an estimated $25.5M increase.
- De Burlo Group's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $18.3M.
- De Burlo Group fully exited Intuitive Surgical in Q3 2025, selling an estimated $19.5M.
- De Burlo Group's ten largest holdings make up 42% of its $830M portfolio in Q3 2025.
- De Burlo Group opened 4 new positions and closed 6 in Q3 2025.
- De Burlo Group's portfolio value rose 9.3% quarter-over-quarter to $830M.
Based on De Burlo Group's 13F filing for Q3 2025, filed 13 Nov 2025.